Table 5. Extent of visual loss at presentation and BCVA at two months follow-up after treatment.

Visual Acuity	No. of cases at presentation	Per cent	No. of cases at 2 months follow-up	Per cent
< 6/60	16	26.67	41	68.33
6/60 – 3/60	24	40	10	16.67
3/60 – 1/60	15	25	4	6.66
PL present	1	1.67	1	1.67
No PL	4	6.66	4	6.66
Total	60	100	60	100